Standout Papers

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity 2024 2026101
  1. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity (2024)
    Charlotte Baker, Ty J. Gluckman et al. JAMA Internal Medicine
  2. Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity (2025)
    Vincent Zhang, Charlotte Baker et al. JAMA Network Open

Immediate Impact

15 standout
Sub-graph 1 of 6

Citing Papers

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2025 Standout
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
2025 Standout
1 intermediate paper

Works of Charlotte Baker being referenced

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
2024 Standout
Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
2017

Author Peers

Author Last Decade Papers Cites
Charlotte Baker 41 25 5 108 65 27 289
Domenico Russo 43 6 6 31 22 29 323
Erkan Şengül 20 78 4 58 16 25 334
Hamlet Gasoyan 31 16 18 94 79 33 304
Cem Tanrıöver 15 28 10 61 21 24 257
Jian Mao 24 45 5 27 22 21 312
Hasan Kayabaşı 12 58 23 29 25 34 315
Chiara Moretti 23 39 17 62 7 24 326
D. Fleury 25 24 6 67 13 29 311
Alexander Haubenstock 16 13 35 10 26 289
Bruno Salgado Riveros 17 68 14 35 28 28 267

All Works

Loading papers...

Rankless by CCL
2026